**Weekly News Sentiment:** Neutral to Negative

**Notable Events:**

1. Sun Pharma's Q4 results were announced, with a 19% YoY decline in profit, which led to a fall in share price.
2. The company declared a dividend of ₹5.50 per share.
3. JM Financial retained a "Buy" rating on Sun Pharma, but lowered the target price to ₹2,025.
4. Trading volume in Sun Pharma shares surged.

**News Tone:**

The news tone for Sun Pharma is neutral to negative this week. The Q4 results were disappointing, leading to a decline in share price. The dividend declaration was a positive, but it was not enough to offset the negative sentiment around the results. The retained "Buy" rating from JM Financial was also tempered by the lowered target price. Overall, the news tone is more negative than positive, with a few neutral events.

**Price Impact:**

Based on the historical data, the price impact of similar news events has been mostly negative, with a few positive exceptions. The average impact has been around -2% to -4%.